slotkoers
Korea S.E.
00:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.015
KRW
|
+0,84%
|
|
+1,34%
|
-13,61%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
459.672
|
421.046
|
398.131
|
235.942
|
204.970
|
252.174
|
Bedrijfswaarde
1 |
953.408
|
889.093
|
841.156
|
619.429
|
594.039
|
652.258
|
K/w-verhouding
|
19,5
x
|
-12,6
x
|
44
x
|
-85,5
x
|
9,25
x
|
13,2
x
|
Dividendrendement
|
1,19%
|
1,42%
|
1,5%
|
2,55%
|
3,36%
|
2,95%
|
Marktkapitalisatie/omzet
|
0,63
x
|
0,58
x
|
0,51
x
|
0,3
x
|
0,24
x
|
0,27
x
|
Bedrijfswaarde/omzet
|
1,31
x
|
1,22
x
|
1,08
x
|
0,79
x
|
0,69
x
|
0,7
x
|
Bedrijfswaarde/EBITDA
|
14
x
|
19,8
x
|
10,5
x
|
6,16
x
|
3,94
x
|
3,47
x
|
Bedrijfswaarde/FCF
|
10,3
x
|
5,95
x
|
64,2
x
|
5,86
x
|
15,6
x
|
54,6
x
|
FCF Yield
|
9,73%
|
16,8%
|
1,56%
|
17,1%
|
6,4%
|
1,83%
|
Price to Book
|
2,48
x
|
2,82
x
|
3,65
x
|
2,53
x
|
1,92
x
|
2,03
x
|
Aantal aandelen (in duizenden)
|
73.909
|
73.904
|
73.898
|
72.269
|
72.262
|
72.256
|
Referentieprijs
2 |
6.219
|
5.697
|
5.388
|
3.265
|
2.836
|
3.490
|
Datum van publicatie
|
26-03-19
|
25-03-20
|
25-03-21
|
28-03-22
|
21-03-23
|
18-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
725.382
|
726.424
|
781.515
|
788.937
|
864.536
|
928.072
|
EBITDA
1 |
68.277
|
44.907
|
80.239
|
100.519
|
150.831
|
187.887
|
Bedrijfsresultaat (EBIT)
1 |
33.315
|
2.736
|
37.329
|
62.136
|
110.705
|
143.665
|
Operationele Marge
|
4,59%
|
0,38%
|
4,78%
|
7,88%
|
12,81%
|
15,48%
|
Resultaat voor belastingen (EBT)
1 |
427,2
|
-26.082
|
23.598
|
32.488
|
70.995
|
53.390
|
Nettowinst (verlies)
1 |
23.169
|
-33.441
|
9.064
|
-2.778
|
22.152
|
19.026
|
Nettomarge
|
3,19%
|
-4,6%
|
1,16%
|
-0,35%
|
2,56%
|
2,05%
|
WPA
2 |
319,8
|
-452,5
|
122,4
|
-38,18
|
306,5
|
265,3
|
Free Cash Flow
1 |
92.729
|
149.496
|
13.107
|
105.751
|
38.009
|
11.944
|
FCF-marge
|
12,78%
|
20,58%
|
1,68%
|
13,4%
|
4,4%
|
1,29%
|
Kasstroomconversie (ebitda)
|
135,81%
|
332,9%
|
16,34%
|
105,2%
|
25,2%
|
6,36%
|
Kasstroomconversie (nettowinst)
|
400,22%
|
-
|
144,61%
|
-
|
171,58%
|
62,78%
|
Dividend per aandeel
2 |
74,04
|
80,75
|
80,75
|
83,17
|
95,18
|
102,9
|
Datum van publicatie
|
26-03-19
|
25-03-20
|
25-03-21
|
28-03-22
|
21-03-23
|
18-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
493.735
|
468.047
|
443.024
|
383.486
|
389.069
|
400.084
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
7,231
x
|
10,42
x
|
5,521
x
|
3,815
x
|
2,58
x
|
2,129
x
|
Free Cash Flow
1 |
92.729
|
149.496
|
13.107
|
105.751
|
38.009
|
11.944
|
ROE (netto-inkomsten/eigen vermogen)
|
-1,77%
|
-8,41%
|
1,03%
|
1,41%
|
14,6%
|
9,1%
|
ROA (netto-inkomsten/totale activa)
|
1,59%
|
0,14%
|
1,99%
|
3,56%
|
6,22%
|
7,69%
|
Totale activa
1 |
1.459.385
|
-24.643.215
|
454.573
|
-77.958
|
355.919
|
247.268
|
Nettoactief per aandeel
2 |
2.509
|
2.024
|
1.478
|
1.290
|
1.481
|
1.716
|
Cashflow per aandeel
2 |
1.028
|
1.566
|
416,0
|
649,0
|
837,0
|
1.023
|
Capex
1 |
23.459
|
18.851
|
51.883
|
37.487
|
67.628
|
71.080
|
Capex/omzet
|
3,23%
|
2,6%
|
6,64%
|
4,75%
|
7,82%
|
7,66%
|
Datum van publicatie
|
26-03-19
|
25-03-20
|
25-03-21
|
28-03-22
|
21-03-23
|
18-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -13,61% | 158 mln. | | +19,98% | 43,67 mld. | | +20,67% | 22,51 mld. | | +14,63% | 14,6 mld. | | +14,32% | 13,74 mld. | | +44,72% | 11,91 mld. | | -8,37% | 7,04 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +10,21% | 5,42 mld. |
Generieke geneesmiddelen
|